IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
IMF Deputy Dan Katz Visits China as Key Economic Review Nears 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows 
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data 
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets 
Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Johnson & Johnson has settled another case this year, and this time for its case in Australia concerning the pelvic mesh class action lawsuit. It was reported that the healthcare and pharmaceutical company headquartered in New Brunswick, New Jersey reached a $204.9 million or AUS$300 million agreement to settle two suits.
The settlement has been described as the biggest in the country's history but is still subject to federal court approval. The class action suits were filed by Shine Lawyers on behalf of the Australian women.
The Brisbane-based law firm that specializes in personal injury compensation law filed two lawsuits against Johnson & Johnson. The lawyers said on Monday, Sept. 12 that it sued the company for the sale of defective pelvic mesh implants to Australian women.
The Shine Lawyers affirmed that this is the largest settlement in a product-liability class action in the entire history of Australia. The settlement was reached after a number of court proceedings with over 11,000 claimants. Johnson & Johnson's subsidiary, Ethicon Inc., was also involved in the lawsuit, as per Reuters.
The settlement earlier this week also revealed that the Australian federal court judge previously found Ethicon to have sold the mesh implants used for treating urinary incontinence and pelvic organ prolapse. The court said the company sold the device without warning surgeons and women about the risks.
The judge further said Ethicon rushed the products and released them to the market before proper testing could be done. In response to the settlement, Johnson & Johnson's spokesman said, "Pending the Federal Court approval, we are pleased to reach a settlement that provides certainty and a path forward for eligible Australian patients."
The Guardian reported that women who had implants using the mesh suffered complications such as cuts through internal tissue, fistula formation, vaginal scarring, painful sex, and pains in the back, pelvic and leg areas. Some of these complications may be difficult to treat and could occur years after surgery. Finally, Rebecca Jancauskas of Shine Lawyers said the Johnson & Johnson settlement would be very helpful to women who are undergoing treatments for complications.
"We welcome this settlement which brings the litigation to an end," the lawyer said "If the federal court approves the settlement our focus will shift to the important task of distributing the settlement to group members."
